About Neumous
Neumous is a company based in Cheongju (South Korea) founded in 2022. It operates as a B2B. Neumous operates in a competitive market with competitors including Impel NeuroPharma, CraniUS, Cognos Therapeutics, Bionxt and NsGene, among others.
- Headquarter Cheongju, South Korea
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Neumous
Detailed funding history for Neumous
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neumous
Investment portfolio details for Neumous
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neumous
Detailed financials for Neumous
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neumous Comparisons
Peer comparison for Neumous
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neumous
Neumous operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Impel NeuroPharma, CraniUS, Cognos Therapeutics, Bionxt and NsGene, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Intranasal delivery technology for CNS diseases is developed.
|
|
| Locked | Locked | Locked |
Drug delivery systems for brain diseases and disorders are developed.
|
|
| Locked | Locked | Locked |
Cognos Therapeutics is focused on innovative neurological and oncological treatments.
|
|
| Locked | Locked | Locked |
Drug formulations and delivery systems for diseases are developed.
|
|
| Locked | Locked | Locked |
Specializes in drug delivery systems and therapeutics for central nervous system diseases.
|
|
| Locked | Locked | Locked |
Non-invasive ultrasound device for blood-brain barrier is developed.
|
Detailed competitors of Neumous
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neumous
Complete news archive for Neumous
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neumous
Neumous was founded in 2022.
Neumous is headquartered in Cheongju, South Korea. It is registered at Cheongju, Chungcheongbuk-do, South Korea.
Neumous, based in Cheongju, focuses on providing healthcare solutions, developing medical devices, neurology, and ultrasound technology. Develops innovative non-invasive ultrasound technologies for treating brain diseases without surgery. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Neumous's top competitors include Impel NeuroPharma, CraniUS and Cognos Therapeutics.